Ajanta Pharma Limited (IN:AJANTPHARM)
:AJANTPHARM
Total Valuation
Ajanta Pharma Limited has a market cap or net worth of ₹350.26B. The enterprise value is ₹352.12B.
Market Cap₹350.26B
Enterprise Value₹352.12B
Share Statistics
Ajanta Pharma Limited has 124,935,620 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding124,935,620
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ajanta Pharma Limited’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 21.66%.
Return on Equity (ROE)0.24
Return on Assets (ROA)0.18
Return on Invested Capital (ROIC)21.66%
Return on Capital Employed (ROCE)0.28
Revenue Per Employee5.68M
Profits Per Employee1.14M
Employee Count8,073
Asset Turnover0.91
Inventory Turnover1.25
Valuation Ratios
The current PE Ratio of Ajanta Pharma Limited is 31.6. Ajanta Pharma Limited’s PEG ratio is 2.64.
PE Ratio31.6
PS Ratio7.14
PB Ratio8.64
Price to Fair Value8.64
Price to FCF39.04
Price to Operating Cash Flow123.47
PEG Ratio2.64
Income Statement
In the last 12 months, Ajanta Pharma Limited had revenue of 45.88B and earned 9.20B in profits. Earnings per share was 73.56.
Revenue45.88B
Gross Profit34.60B
Operating Income11.28B
Pretax Income11.89B
Net Income9.20B
EBITDA13.54B
Earnings Per Share (EPS)73.56
Cash Flow
In the last 12 months, operating cash flow was 2.84B and capital expenditures -1.73B, giving a free cash flow of 1.10B billion.
Operating Cash Flow2.84B
Free Cash Flow1.10B
Free Cash Flow per Share8.84
Dividends & Yields
Ajanta Pharma Limited pays an annual dividend of ₹28, resulting in a dividend yield of 1.04%
Dividend Per Share₹28
Dividend Yield1.04%
Payout Ratio35.98%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.41
52-Week Price Change8.11%
50-Day Moving Average2.89K
200-Day Moving Average2.66K
Relative Strength Index (RSI)45.54
Average Volume (3m)2.10K
Important Dates
Ajanta Pharma Limited upcoming earnings date is Apr 30, 2026, TBA (Confirmed).
Last Earnings DateJan 30, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
Ajanta Pharma Limited as a current ratio of 2.85, with Debt / Equity ratio of 5.70%
Current Ratio2.85
Quick Ratio1.95
Debt to Market Cap<0.01
Net Debt to EBITDA-0.10
Interest Coverage Ratio54.44
Taxes
In the past 12 months, Ajanta Pharma Limited has paid 2.69B in taxes.
Income Tax2.69B
Effective Tax Rate0.23
Enterprise Valuation
Ajanta Pharma Limited EV to EBITDA ratio is 24.10, with an EV/FCF ratio of 38.88.
EV to Sales7.11
EV to EBITDA24.10
EV to Free Cash Flow38.88
EV to Operating Cash Flow28.20
Balance Sheet
Ajanta Pharma Limited has ₹9.40B in cash and marketable securities with ₹2.46B in debt, giving a net cash position of ₹6.94B billion.
Cash & Marketable Securities₹9.40B
Total Debt₹2.46B
Net Cash₹6.94B
Net Cash Per Share₹55.56
Tangible Book Value Per Share₹299.09
Margins
Gross margin is 69.29%, with operating margin of 24.60%, and net profit margin of 20.06%.
Gross Margin69.29%
Operating Margin24.60%
Pretax Margin25.92%
Net Profit Margin20.06%
EBITDA Margin29.51%
EBIT Margin26.37%
Analyst Forecast
The average price target for Ajanta Pharma Limited is ₹3,270.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹3,270.00
Price Target Upside11.95% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast10.74%
EPS Growth Forecast11.91%